|
Marché Fermé -
NYSE
22:03:15 04/09/2026
|
Pré-ouverture 13:28:36 | |||
| 1 149,36 USD | -0,88% |
|
1 142,70 | -0,58% |
| 13:00 | Le traitement expérimental de Roivant contre une maladie pulmonaire atteint ses objectifs en phase intermédiaire | RE |
| 07/09 | Echec d'un essai de phase III pour Novartis |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (N) | Rendement du dividende (N+1) | PER (N) | Price to Book (N) | VE / CA (N) | VE / EBITDA (N) | VE / EBIT (N) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| 0,6% | 0,67% | 32.72x | 20.76x | 11.9x | 24.26x | 25.57x | 1 024 Md | ||
| 1,95% | 2,04% | 30.62x | - | - | - | - | 663 Md | ||
| 2,67% | 2,81% | 32.73x | -359.23x | 7.6x | 15.8x | 16.42x | 453 Md | ||
| 2,83% | 2,9% | 19.22x | 7.03x | 4.69x | 11.6x | 12.86x | 349 Md | ||
| 2,82% | 2,94% | 22.02x | 6.23x | 5.68x | 14.1x | 15.03x | 295 Md | ||
| 2,05% | 2,18% | 20.97x | 4.69x | 4.3x | 12.3x | 12.93x | 253 Md | ||
| 2,31% | 2,44% | 27.66x | 20.89x | 7.14x | 13.16x | 16.38x | 236 Md | ||
| 3,78% | 3,76% | 13.33x | 5.65x | 4.82x | 10.06x | 11.7x | 206 Md | ||
| 2,18% | 2,25% | -46.14x | 10.28x | 6.65x | 25.95x | 63.22x | 187 Md | ||
| 6,05% | 6,1% | 17.83x | 1.85x | 3.37x | 8.6x | 9.81x | 162 Md | ||
| -.--% | -.--% | 32.2x | 7.23x | 9.69x | 29.39x | 27.19x | 138 Md | ||
| 3,78% | 3,85% | 11.9x | 5.61x | 3.31x | 8.6x | 9.32x | 136 Md | ||
| 5,62% | 5,94% | 12.05x | 1.23x | 2.14x | 6.93x | 7.73x | 105 Md | ||
| 3,79% | 4,08% | 13.92x | 4.49x | 2.75x | 8.16x | 9.09x | 99,72 Md | ||
| 2,07% | 2,36% | 21.34x | 4.81x | 7.12x | 13.52x | 14.19x | 70,01 Md | ||
| 3,54% | 3,61% | 45.74x | 1.24x | 2.79x | 9.87x | 27.93x | 59,8 Md | ||
| 0,33% | 1,15% | 22.08x | 1.7x | 1.7x | 8.03x | 13.79x | 55,64 Md | ||
| 0,53% | 0,6% | 33.22x | 4.48x | 7.79x | 26.39x | 27.6x | 45,39 Md | ||
| -.--% | -.--% | 48.78x | 4.91x | 3.27x | 12.07x | 13.65x | 42,37 Md | ||
| 2,35% | 2,6% | 17.88x | 1.79x | 3.26x | 12.16x | 13.55x | 40,96 Md | ||
| Moyenne | 2,46% | 2,61% | 21,50x | -12,86x | 5,26x | 14,26x | 18,31x | 231,19 Md | |
| Moyenne pondérée par Capi. | 2,2% | 2,3% | 23,62x | -31,41x | 7,12x | 16,60x | 19,72x |
- Bourse
- Actions
- Action LLY
- Secteur Eli Lilly and Company
- Dividendes sectoriels
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















